Tag: Chinese pharmaceutical market

Browse exclusive Tags!

AstraZeneca to Acquire Gracell Biotechnologies, Expanding Cell Therapy Ambitions in China

AstraZeneca's $1.2B acquisition of Gracell Biotechnologies expands its cell therapy capabilities and presence in China's pharmaceutical market, strengthening its position and commitment to innovative treatments.

Popular

Subscribe

spot_imgspot_img